C.R.S. Section 12-280-502
Therapeutic interchange and therapeutically equivalent selections for nursing care facility or long-term acute care hospital patients

  • rules

(1)

A pharmacy used by a nursing care facility or a long-term acute care hospital licensed under part 1 of article 3 of title 25 may make a therapeutic interchange or a therapeutically equivalent selection for a patient if, during the patient’s stay at the facility, the selection has been approved for the patient:

(a)

In accordance with written guidelines and procedures for making therapeutic interchange or therapeutically equivalent selections, as maintained in a current and readily available manner at the dispensing prescription drug outlet and as developed by a quality assessment and assurance committee that includes a pharmacist licensed under this article 280 and is formed by the facility in accordance with 42 CFR 483.75; and

(b)

By one of the following health-care providers:

(I)

A physician licensed under article 240 of this title 12;

(II)

A physician assistant licensed under section 12-240-113; or

(III)

An advanced practice registered nurse prescriber licensed as a professional nurse under section 12-255-110, registered as an advanced practice registered nurse under section 12-255-111, and authorized to prescribe controlled substances or prescription drugs pursuant to section 12-255-112.

(2)

The board may adopt rules as necessary to implement this part 5.

Source: Section 12-280-502 — Therapeutic interchange and therapeutically equivalent selections for nursing care facility or long-term acute care hospital patients - rules, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-12.­pdf (accessed Dec. 24, 2024).

12–280–101
Public interest - rules
12–280–102
Applicability of common provisions
12–280–103
Definitions - rules
12–280–104
State board of pharmacy - creation - subject to review - repeal of parts
12–280–105
Membership of board - removal - compensation - meetings
12–280–106
Veterinary pharmaceutical advisory committee - creation - appointments - rules - repeal
12–280–107
Rules
12–280–108
Powers and duties - rules
12–280–109
Drugs, devices, and other materials
12–280–110
Publications
12–280–111
Malpractice claims information - not public - exception
12–280–112
Fees
12–280–113
Approval of schools
12–280–114
Licensure, certification, or registration - applicability - applications - licensure and certification requirements - rules
12–280–115
Exemptions from licensure - hospital residency programs - home renal dialysis - research companies
12–280–115.5
Certification of pharmacy technicians - requirements - provisional certification - criminal history record check - rules
12–280–116
Expiration and renewal of licenses, certifications, or registrations
12–280–117
Continuing education - exceptions - inactive status
12–280–117.5
Continuing education for pharmacy technicians - exceptions - inactive status
12–280–118
Prescription drug outlet under charge of pharmacist - rules
12–280–119
Registration of facilities - rules
12–280–120
Compounding - dispensing - sale of drugs and devices - rules - definition
12–280–121
Compounding drugs for office use by a veterinarian - rules - definitions
12–280–122
Limited authority to delegate activities constituting practice of pharmacy to pharmacy interns or pharmacy technicians
12–280–123
Prescription required - exception - dispensing opiate antagonists - selling nonprescription syringes and needles
12–280–124
Labeling - rules
12–280–125
Substitution of prescribed drugs and biological products authorized - when - conditions
12–280–125.3
Pharmacists’ authority - minor prescription adaptions
12–280–125.5
Pharmacists’ authority to dispense chronic maintenance drugs - rules - liability
12–280–125.7
Pharmacists’ authority to prescribe and dispense HIV prevention drugs - definitions - rules
12–280–126
Unprofessional conduct - grounds for discipline
12–280–127
Disciplinary actions
12–280–128
Judicial review
12–280–129
Unlawful acts - civil fines
12–280–130
Unauthorized practice - penalties
12–280–131
New drugs - when sales permissible
12–280–132
Advertising of prescription drug prices
12–280–133
Nonresident prescription drug outlet - registration
12–280–133.5
Nonresident 503B outsourcing facility - registration - requirements - denial, revocation, or suspension - rules
12–280–133.7
Third-party logistics providers - registration - denial, revocation, or suspension - rules
12–280–134
Records
12–280–135
Unused medication - licensed facilities - correctional facilities - reuse - definitions - rules
12–280–136
Confidential agreement to limit practice
12–280–137
Investigations of suspicious drugs
12–280–138
Patient counseling - pharmacists required to perform - patient may decline - rules
12–280–139
Insulin affordability program - record keeping - reimbursement - definitions
12–280–140
Emergency prescription insulin supply - eligibility - record keeping
12–280–141
Prescription drugs - automated pharmacy dispensing system - rules - definition
12–280–142
Epinephrine auto-injector affordability program - record keeping - reimbursement - definitions
12–280–201
Legislative declaration
12–280–202
Definitions
12–280–203
Pharmacy peer health assistance fund - rules
12–280–204
Eligibility - participants
12–280–205
Liability
12–280–206
Immunity
12–280–301
Definitions
12–280–303
Wholesaler registration requirements - rules
12–280–304
Record check
12–280–305
Restrictions on transactions
12–280–306
Records - pedigree - compliance with DQSA
12–280–307
Penalty
12–280–308
Manufacturer, agent, representative, or employee - drug cost information - required - definitions
12–280–401
Legislative declaration
12–280–402
Definitions
12–280–403
Prescription drug use monitoring program - registration required - applications - rules - appropriation - repeal
12–280–404
Program operation - access - rules - definitions
12–280–405
Prescription drug monitoring fund - creation - fee
12–280–406
Violations - penalties
12–280–407
Prescription drug outlets - prescribers - responsibilities - liability
12–280–408
Exemption - waiver
12–280–409
Examination and analysis of prescription drug monitoring program - recommendations to executive director
12–280–501
Written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections
12–280–502
Therapeutic interchange and therapeutically equivalent selections for nursing care facility or long-term acute care hospital patients - rules
12–280–601
Definitions
12–280–602
Collaborative pharmacy practice agreements - pharmacist requirements
12–280–603
Rules
Green check means up to date. Up to date

Current through Fall 2025

§ 12-280-502’s source at colorado​.gov